These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25620184)

  • 1. The immunomodulatory molecule pidotimod induces the expression of the NOD-like receptor NLRP12 and attenuates TLR-induced inflammation.
    Fogli M; Caccuri F; Iaria ML; Giagulli C; Corbellini S; Campilongo F; Caruso A; Fiorentini S
    J Biol Regul Homeost Agents; 2014; 28(4):753-66. PubMed ID: 25620184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3).
    Caccuri F; Bugatti A; Corbellini S; Roversi S; Zani A; Mazzuca P; Marsico S; Caruso A; Giagulli C
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of airway epithelial cell functions by Pidotimod: NF-kB cytoplasmatic expression and its nuclear translocation are associated with an increased TLR-2 expression.
    Carta S; Silvestri M; Rossi GA
    Ital J Pediatr; 2013 May; 39():29. PubMed ID: 23663325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia.
    Esposito S; Garziano M; Rainone V; Trabattoni D; Biasin M; Senatore L; Marchisio P; Rossi M; Principi N; Clerici M
    J Transl Med; 2015 Sep; 13():288. PubMed ID: 26335787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory effects of pidotimod in adults with community-acquired pneumonia undergoing standard antibiotic therapy.
    Trabattoni D; Clerici M; Centanni S; Mantero M; Garziano M; Blasi F
    Pulm Pharmacol Ther; 2017 Jun; 44():24-29. PubMed ID: 28302543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.
    Uehara A; Yang S; Fujimoto Y; Fukase K; Kusumoto S; Shibata K; Sugawara S; Takada H
    Cell Microbiol; 2005 Jan; 7(1):53-61. PubMed ID: 15617523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pattern-recognition receptor nucleotide-binding oligomerization domain--containing protein 1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts.
    Yokota K; Miyazaki T; Hemmatazad H; Gay RE; Kolling C; Fearon U; Suzuki H; Mimura T; Gay S; Ospelt C
    Arthritis Rheum; 2012 May; 64(5):1329-37. PubMed ID: 22143988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases.
    Mitchell D; Olive C
    Mol Immunol; 2010 Jul; 47(11-12):2065-73. PubMed ID: 20451253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.
    Giagulli C; Noerder M; Avolio M; Becker PD; Fiorentini S; Guzman CA; Caruso A
    Int Immunopharmacol; 2009 Nov; 9(12):1366-73. PubMed ID: 19712757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulatory peptide pidotimod facilitates M2 macrophage polarization and its function.
    Hu S; Fu X; Fu A; Du W; Ji J; Li W
    Amino Acids; 2014 May; 46(5):1177-85. PubMed ID: 24481486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
    Sukkar MB; Xie S; Khorasani NM; Kon OM; Stanbridge R; Issa R; Chung KF
    J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts.
    Ospelt C; Brentano F; Jüngel A; Rengel Y; Kolling C; Michel BA; Gay RE; Gay S
    Arthritis Rheum; 2009 Feb; 60(2):355-63. PubMed ID: 19180502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pidotimod on the immune and the neuroendocrine system in the aging rat.
    Chiarenza A; Iurato MP; Barbera N; Lempereur L; Cantarella G; Scapagnini U; Scapagnini G; Bernardini R
    Arzneimittelforschung; 1994 Dec; 44(12A):1437-40. PubMed ID: 7857338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of TRAF6 and pro-inflammatory cytokines through activation of TLR2, TLR4, NOD1, and NOD2 in human periodontal ligament fibroblasts.
    Tang L; Zhou XD; Wang Q; Zhang L; Wang Y; Li XY; Huang DM
    Arch Oral Biol; 2011 Oct; 56(10):1064-72. PubMed ID: 21457942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced application of porcine intestinal epithelial cells for the selection of immunobiotics modulating toll-like receptor 3-mediated inflammation.
    Hosoya S; Villena J; Chiba E; Shimazu T; Suda Y; Aso H; Saito T; Kitazawa H
    J Microbiol Immunol Infect; 2013 Dec; 46(6):474-81. PubMed ID: 22727542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
    Arsenault RJ; Kogut MH; He H
    Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pidotimod increases inflammation in wounded zebrafish embryos.
    Ding L; Luo K; Feng CG; Oehlers SH
    Fish Shellfish Immunol; 2022 Jan; 120():429-433. PubMed ID: 34922016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multifaceted nature of NLRP12.
    Tuncer S; Fiorillo MT; Sorrentino R
    J Leukoc Biol; 2014 Dec; 96(6):991-1000. PubMed ID: 25249449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of toll-like receptors on human adipose-derived stromal cells.
    Hwa Cho H; Bae YC; Jung JS
    Stem Cells; 2006 Dec; 24(12):2744-52. PubMed ID: 16902195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in the development of Toll-like receptor (TLR) antagonists.
    Patra MC; Choi S
    Expert Opin Ther Pat; 2016 Jun; 26(6):719-30. PubMed ID: 27136061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.